 | • レポートコード：D0GIR-01077 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん免疫療法薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。がん免疫療法薬の種類別市場規模（モノクローナル抗体、チェックポイント阻害剤、インターフェロン、インターロイキン）、用途別市場規模（肺がん、肝がん、大腸がん、膵臓がん、乳がん、その他がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Amgen、Novartis、Pfizer、GlaxoSmithKline、Merck、Boehringer Ingelheim、Sanofi、Johnson & Johnson、AbbVie、AstraZeneca、Immatics Biotechnologies ・地域別グローバル市場分析 2015年-2020年 ・がん免疫療法薬の北米市場（アメリカ、カナダ、メキシコ） ・がん免疫療法薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん免疫療法薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん免疫療法薬の南米市場（ブラジル、アルゼンチン） ・がん免疫療法薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：モノクローナル抗体、チェックポイント阻害剤、インターフェロン、インターロイキン ・用途別分析：肺がん、肝がん、大腸がん、膵臓がん、乳がん、その他がん ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Cancers Immunotherapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Cancers Immunotherapy Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Cancers Immunotherapy Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancers Immunotherapy Drugs market has been segmented into:
Monoclonal Antibodies
Check Point Inhibitors
Interferons
Interleukins
By Application, Cancers Immunotherapy Drugs has been segmented into:
Lung Cancer
Liver Cancer
Colorectal Cancer
Pancreatic Cancer
Breast Cancer
Other Cancers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancers Immunotherapy Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancers Immunotherapy Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancers Immunotherapy Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Cancers Immunotherapy Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancers Immunotherapy Drugs Market Share Analysis
Cancers Immunotherapy Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancers Immunotherapy Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancers Immunotherapy Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Cancers Immunotherapy Drugs are:
Roche
Amgen
Novartis
Pfizer
GlaxoSmithKline
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
AbbVie
AstraZeneca
Immatics Biotechnologies
Among other players domestic and global, Cancers Immunotherapy Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Cancers Immunotherapy Drugs Market Overview
1.1 Product Overview and Scope of Cancers Immunotherapy Drugs
1.2 Classification of Cancers Immunotherapy Drugs by Type
1.2.1 Global Cancers Immunotherapy Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancers Immunotherapy Drugs Revenue Market Share by Type in 2019
1.2.3 Monoclonal Antibodies
1.2.4 Check Point Inhibitors
1.2.5 Interferons
1.2.6 Interleukins
1.3 Global Cancers Immunotherapy Drugs Market by Application
1.3.1 Overview: Global Cancers Immunotherapy Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lung Cancer
1.3.3 Liver Cancer
1.3.4 Colorectal Cancer
1.3.5 Pancreatic Cancer
1.3.6 Breast Cancer
1.3.7 Other Cancers
1.4 Global Cancers Immunotherapy Drugs Market by Regions
1.4.1 Global Cancers Immunotherapy Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancers Immunotherapy Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancers Immunotherapy Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancers Immunotherapy Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancers Immunotherapy Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancers Immunotherapy Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancers Immunotherapy Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Product and Services
2.6.4 Merck Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Product and Services
2.7.4 Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Product and Services
2.8.4 Sanofi Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Product and Services
2.9.4 Johnson & Johnson Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Product and Services
2.10.4 AbbVie Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Product and Services
2.11.4 AstraZeneca Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Immatics Biotechnologies
2.12.1 Immatics Biotechnologies Details
2.12.2 Immatics Biotechnologies Major Business
2.12.3 Immatics Biotechnologies Product and Services
2.12.4 Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancers Immunotherapy Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancers Immunotherapy Drugs Players Market Share
3.2.2 Top 10 Cancers Immunotherapy Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancers Immunotherapy Drugs Revenue and Market Share by Regions
4.2 North America Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
5 North America Cancers Immunotherapy Drugs Revenue by Countries
5.1 North America Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
5.2 USA Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
6 Europe Cancers Immunotherapy Drugs Revenue by Countries
6.1 Europe Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
6.2 Germany Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
6.4 France Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancers Immunotherapy Drugs Revenue by Countries
7.1 Asia-Pacific Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
7.2 China Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
7.5 India Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
8 South America Cancers Immunotherapy Drugs Revenue by Countries
8.1 South America Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
8.2 Brazil Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancers Immunotherapy Drugs by Countries
9.1 Middle East & Africa Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancers Immunotherapy Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Cancers Immunotherapy Drugs Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.4 Check Point Inhibitors Revenue Growth Rate (2015-2025)
10.5 Interferons Revenue Growth Rate (2015-2025)
10.6 Interleukins Revenue Growth Rate (2015-2025)
11 Global Cancers Immunotherapy Drugs Market Segment by Application
11.1 Global Cancers Immunotherapy Drugs Revenue Market Share by Application (2015-2020)
11.2 Cancers Immunotherapy Drugs Market Forecast by Application (2019-2024)
11.3 Lung Cancer Revenue Growth (2015-2020)
11.4 Liver Cancer Revenue Growth (2015-2020)
11.5 Colorectal Cancer Revenue Growth (2015-2020)
11.6 Pancreatic Cancer Revenue Growth (2015-2020)
11.7 Breast Cancer Revenue Growth (2015-2020)
11.8 Other Cancers Revenue Growth (2015-2020)
12 Global Cancers Immunotherapy Drugs Market Size Forecast (2021-2025)
12.1 Global Cancers Immunotherapy Drugs Market Size Forecast (2021-2025)
12.2 Global Cancers Immunotherapy Drugs Market Forecast by Regions (2021-2025)
12.3 North America Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
12.6 South America Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancers Immunotherapy Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancers Immunotherapy Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancers Immunotherapy Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancers Immunotherapy Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cancers Immunotherapy Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Corporate Information, Location and Competitors
Table 7. Roche Cancers Immunotherapy Drugs Major Business
Table 8. Roche Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Roche SWOT Analysis
Table 10. Roche Cancers Immunotherapy Drugs Product and Solutions
Table 11. Roche Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Amgen Corporate Information, Location and Competitors
Table 13. Amgen Cancers Immunotherapy Drugs Major Business
Table 14. Amgen Cancers Immunotherapy Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Amgen SWOT Analysis
Table 16. Amgen Cancers Immunotherapy Drugs Product and Solutions
Table 17. Amgen Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Novartis Corporate Information, Location and Competitors
Table 19. Novartis Cancers Immunotherapy Drugs Major Business
Table 20. Novartis Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Novartis SWOT Analysis
Table 22. Novartis Cancers Immunotherapy Drugs Product and Solutions
Table 23. Novartis Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Pfizer Corporate Information, Location and Competitors
Table 25. Pfizer Cancers Immunotherapy Drugs Major Business
Table 26. Pfizer Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Pfizer SWOT Analysis
Table 28. Pfizer Cancers Immunotherapy Drugs Product and Solutions
Table 29. Pfizer Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. GlaxoSmithKline Corporate Information, Location and Competitors
Table 31. GlaxoSmithKline Cancers Immunotherapy Drugs Major Business
Table 32. GlaxoSmithKline Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 33. GlaxoSmithKline SWOT Analysis
Table 34. GlaxoSmithKline Cancers Immunotherapy Drugs Product and Solutions
Table 35. GlaxoSmithKline Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Merck Corporate Information, Location and Competitors
Table 37. Merck Cancers Immunotherapy Drugs Major Business
Table 38. Merck Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Merck SWOT Analysis
Table 40. Merck Cancers Immunotherapy Drugs Product and Solutions
Table 41. Merck Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 43. Boehringer Ingelheim Cancers Immunotherapy Drugs Major Business
Table 44. Boehringer Ingelheim Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Boehringer Ingelheim SWOT Analysis
Table 46. Boehringer Ingelheim Cancers Immunotherapy Drugs Product and Solutions
Table 47. Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Sanofi Corporate Information, Location and Competitors
Table 49. Sanofi Cancers Immunotherapy Drugs Major Business
Table 50. Sanofi Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Sanofi SWOT Analysis
Table 52. Sanofi Cancers Immunotherapy Drugs Product and Solutions
Table 53. Sanofi Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Johnson & Johnson Corporate Information, Location and Competitors
Table 55. Johnson & Johnson Cancers Immunotherapy Drugs Major Business
Table 56. Johnson & Johnson Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Johnson & Johnson SWOT Analysis
Table 58. Johnson & Johnson Cancers Immunotherapy Drugs Product and Solutions
Table 59. Johnson & Johnson Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. AbbVie Corporate Information, Location and Competitors
Table 61. AbbVie Cancers Immunotherapy Drugs Major Business
Table 62. AbbVie Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 63. AbbVie SWOT Analysis
Table 64. AbbVie Cancers Immunotherapy Drugs Product and Solutions
Table 65. AbbVie Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. AstraZeneca Corporate Information, Location and Competitors
Table 67. AstraZeneca Cancers Immunotherapy Drugs Major Business
Table 68. AstraZeneca Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 69. AstraZeneca SWOT Analysis
Table 70. AstraZeneca Cancers Immunotherapy Drugs Product and Solutions
Table 71. AstraZeneca Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Immatics Biotechnologies Corporate Information, Location and Competitors
Table 73. Immatics Biotechnologies Cancers Immunotherapy Drugs Major Business
Table 74. Immatics Biotechnologies Cancers Immunotherapy Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Immatics Biotechnologies SWOT Analysis
Table 76. Immatics Biotechnologies Cancers Immunotherapy Drugs Product and Solutions
Table 77. Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Cancers Immunotherapy Drugs Revenue (Million USD) by Players (2015-2020)
Table 79. Global Cancers Immunotherapy Drugs Revenue Share by Players (2015-2020)
Table 80. Global Cancers Immunotherapy Drugs Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Cancers Immunotherapy Drugs Revenue Market Share by Regions (2015-2020)
Table 82. North America Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
Table 83. North America Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Table 84. Europe Cancers Immunotherapy Drugs Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Cancers Immunotherapy Drugs Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Cancers Immunotherapy Drugs Revenue by Countries (2015-2020)
Table 87. South America Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Cancers Immunotherapy Drugs Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Cancers Immunotherapy Drugs Revenue (Million USD) by Type (2015-2020)
Table 91. Global Cancers Immunotherapy Drugs Revenue Share by Type (2015-2020)
Table 92. Global Cancers Immunotherapy Drugs Revenue Forecast by Type (2021-2025)
Table 93. Global Cancers Immunotherapy Drugs Revenue by Application (2015-2020)
Table 94. Global Cancers Immunotherapy Drugs Revenue Share by Application (2015-2020)
Table 95. Global Cancers Immunotherapy Drugs Revenue Forecast by Application (2021-2025)
Table 96. Global Cancers Immunotherapy Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancers Immunotherapy Drugs Picture
Figure 2. Global Cancers Immunotherapy Drugs Revenue Market Share by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Check Point Inhibitors Picture
Figure 5. Interferons Picture
Figure 6. Interleukins Picture
Figure 7. Cancers Immunotherapy Drugs Revenue Market Share by Application in 2019
Figure 8. Lung Cancer Picture
Figure 9. Liver Cancer Picture
Figure 10. Colorectal Cancer Picture
Figure 11. Pancreatic Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Other Cancers Picture
Figure 14. Global Cancers Immunotherapy Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Cancers Immunotherapy Drugs Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Cancers Immunotherapy Drugs Revenue Market Share in 2019
Figure 23. Global Top 10 Players Cancers Immunotherapy Drugs Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Cancers Immunotherapy Drugs Revenue Market Share by Regions (2015-2020)
Figure 27. Global Cancers Immunotherapy Drugs Revenue Market Share by Regions in 2018
Figure 28. North America Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Europe Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 31. South America Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 33. North America Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Figure 34. North America Cancers Immunotherapy Drugs Revenue Market Share by Countries in 2019
Figure 35. USA Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Canada Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Europe Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Cancers Immunotherapy Drugs Revenue Market Share by Countries in 2019
Figure 40. Germany Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 41. UK Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 42. France Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Russia Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Italy Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Cancers Immunotherapy Drugs Revenue Market Share by Countries in 2019
Figure 47. China Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Japan Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Korea Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 50. India Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 52. South America Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. South America Cancers Immunotherapy Drugs Revenue Market Share by Countries in 2019
Figure 54. Brazil Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Cancers Immunotherapy Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Cancers Immunotherapy Drugs Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 59. UAE Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Cancers Immunotherapy Drugs Revenue and Growth Rate (2015-2020)
Figure 62. Global Cancers Immunotherapy Drugs Revenue Share by Type (2015-2020)
Figure 63. Global Cancers Immunotherapy Drugs Revenue Share by Type in 2019
Figure 64. Global Cancers Immunotherapy Drugs Market Share Forecast by Type (2021-2025)
Figure 65. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 66. Global Check Point Inhibitors Revenue Growth Rate (2015-2020)
Figure 67. Global Interferons Revenue Growth Rate (2015-2020)
Figure 68. Global Interleukins Revenue Growth Rate (2015-2020)
Figure 69. Global Cancers Immunotherapy Drugs Revenue Share by Application (2015-2020)
Figure 70. Global Cancers Immunotherapy Drugs Revenue Share by Application in 2019
Figure 71. Global Cancers Immunotherapy Drugs Market Share Forecast by Application (2021-2025)
Figure 72. Global Lung Cancer Revenue Growth Rate (2015-2020)
Figure 73. Global Liver Cancer Revenue Growth Rate (2015-2020)
Figure 74. Global Colorectal Cancer Revenue Growth Rate (2015-2020)
Figure 75. Global Pancreatic Cancer Revenue Growth Rate (2015-2020)
Figure 76. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 77. Global Other Cancers Revenue Growth Rate (2015-2020)
Figure 78. Global Cancers Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Cancers Immunotherapy Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Cancers Immunotherapy Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
Figure 82. Europe Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
Figure 84. South America Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Cancers Immunotherapy Drugs Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
非血液がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Hematological Cancers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Hematological C…- 頭頸部がん治療薬/治療剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …
- 腫瘍溶解性ウイルス免疫療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Oncolytic Virus Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolytic Virus…
- 腫瘍学治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drugs for Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 細胞免疫療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cell-Based Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…